L-365260 | L-365260 : Antagonist of CCKBR
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
CCKBR
  • Ki:2 nM
  • IC50:2 nM
Antagonist
up to 500 nM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Lack of activity (IC50 > 10 >uM) in various other radioligand binding assays including M1 and M2 ace ...

Potency
Cellular
In Vitro

CCKBR

Mode of Action: Antagonist

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm00121a004

In Vivo Validations

Rat
Dose: 5 mg/Kg
Route of delivery: Intravenous
Plasma half life: 35.7 ± 8.0 min
Systemic clearance: 56.8 ± 18.7 mL/min/Kg
Volume of Distribution at Steady-State: 1.80 ± 0.30 L/Kg

PMID Reference: 1355713

Dose: 5 mg/Kg
Route of delivery: Oral
Plasma half life: 143.0 ± 78.0 min
Cmax: 0.061 ± 0.021 ug/mL
Tmax: 47.5 ± 48.6 min
Area Under the Curve:: 13.0 ± 7.2 ug*min/mL
Bioavailability: 13.6%

PMID Reference: 1355713

Dog
Dose: 5 mg/Kg
Route of delivery: Intravenous
Plasma half life: 101.6 ± 34 min
Systemic clearance: 12.4 ± 0.8 mL/min/Kg
Volume of Distribution at Steady-State: 1.57 ± 0.30 L/Kg

PMID Reference: 1355713

Dose: 5 mg/Kg
Route of delivery: Oral
Plasma half life: 109.0 ± 37.0 min
Cmax: 0.300 ± 0.099 ug/mL
Tmax: 109.0 ± 37.0 min
Area Under the Curve:: 35.9 ± 9.2 ug*min/mL
Bioavailability: 8.8 ± 1.9%

PMID Reference: 1355713

Monkey (Rheus)
Dose: 5 mg/Kg
Route of delivery: Intravenous
Plasma half life: 71.7 ± 7 min
Systemic clearance: 12.6 ± 3.3 mL/min/Kg
Volume of Distribution at Steady-State: 1.04 ± 0.12 L/Kg

PMID Reference: 1355713

Dose: 50 mg/Kg
Route of delivery: Oral
Plasma half life: 118.0 ± 37.0 min
Cmax: 0.538 ± 0.346 ug/mL
Tmax: 40.0 ± 16.0 min
Area Under the Curve:: 83.7 ± 59.9 ug*min/mL
Bioavailability: 1.8 ± 1.1%

PMID Reference: 1355713

Negative Control Compounds

(S)-L365260
Notes: S-Enantiomer IC50 = 151 nM in brain

Chemical Information

Molecular Formula C24H22N4O2
SMILEs Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1
InChI InChI=1S/C24H22N4O2/c1-16-9-8-12-18(15-16)25-24(30)27-22-23(29)28(2)20-14-7-6-13-19(20)21(26-22)17-10-4-3-5-11-17/h3-15,22H,1-2H3,(H2,25,27,30)/t22-/m0/s1
Molecular weight 398.17 Da
AlogP 3.9566200000000027
HBond acceptors 6
HBond donors 2
Atoms 52

References

Cross References

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 17 Aug 2022)
Cellular Use Rating
In Model Organisms
This probe, having been disclosed in 1989, was shown to be a selective (~87-fold) antagonist of CCK-B relative to CCK-A. It was also shown to possess reasonable exposure (194 ug/mL at 2 hours) following...
(on 14 Oct 2025)
Cellular Use Rating
In Model Organisms
The compound has been profiled in a smaller GPCR panel including muscarinic receptors, adrenal receptors and histamine receptors. Its in vivo use and doses used varies in different publications.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria